ABT : Summary for Abbott Laboratories Common Stoc - Yahoo Finance

U.S. Markets closed

Abbott Laboratories (ABT)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
43.80+0.04 (+0.09%)
At close: 4:02PM EDT

43.80 0.00 (0.00%)
After hours: 5:41PM EDT

People also watch
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close43.76
Bid0.00 x
Ask0.00 x
Day's Range43.71 - 44.15
52 Week Range36.76 - 45.84
Avg. Volume7,635,537
Market Cap75.69B
PE Ratio (TTM)46.74
Earnings DateN/A
Dividend & Yield1.06 (2.45%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • PR Newswire15 hours ago

    Abbott Introduces Science-Based Nutrition Drinks to Help Patients Have a Better Recovery from Surgery

    ABBOTT PARK, Ill., April 26, 2017 /PRNewswire/ -- More than 48 million surgeries happen in the U.S. each year,1 and for many of those patients, food is off the table in the hours prior to their procedure. According to a new survey of 1,015 Americans, supported by Abbott, a majority (79 percent) of the respondents who had undergone surgery were instructed by a doctor not to eat or drink before their surgery.2 Yet, surgical guidelines from organizations including the American College of Surgeons and the latest research recommend that certain nutrition should be consumed before and after surgery to help patients have a faster recovery, allowing them to get back to daily activities. Ensure® Surgery Immunonutrition Shake is for people to drink in the week leading up to and following surgery to provide nutrients, such as arginine and omega-3 fatty acids EPA and DHA, to help with immune health and recovery.

  • Benzingayesterday

    Global Market For Medical Implants To Hit Nearly $27 Billion In 5 Years

    The market for implantable medical devices — pacemakers, defibrillators, hearing aids and other machines that help the body run — is expected to hit $26.75 billion by 2022, according to a new market research ...

  • Cramer's lightning round: Nobody ever made money betting against this CEO
    CNBC2 days ago

    Cramer's lightning round: Nobody ever made money betting against this CEO

    Jim Cramer rattles off his take on caller favorite stocks, including this health care giant.